Download Your Complimentary Copy of the Agenda

The 7th Genome Editing Therapeutics Summit is your unique forum to learn, network and partner with the brightest minds advancing genome editing therapies from the lab to patients.

80%

Director, VP & C-Suite Speaker Faculty

50:50

Clinical & Preclinical Speakers

64% / 36%

In Vivo / Ex Vivo Agenda

5+

Hours of Meaningful Networking

2

Brand-New Workshops

Explore the 7th Genome Editing Therapeutics Summit 2026 Agenda, covering CRISPR Therapeutics, In Vivo Gene Editing, Ex Vivo Gene Editing, Off-Target Analysis, Prime Editing, Base Editing, Genome Engineering and more

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

AbbVie is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Arbor Biotechnologies is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Beam Therapeutics is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Bristol Myers Squibb is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Cytodigm is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
EG 427 Pinpoint Gene Therapy is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
egenesis is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Eli Lilly & Co. is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Emendo Bio is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Epicrispr Biotechnologies is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Full Circle Therapeutics is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Innovative Genomics Institute is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Intellia Therapeutics is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Komo Biosciences is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Metagenomi Therapeutics is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Prime Medicine is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Sanofi is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
Scribe Therapeutics is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)

Audience Composition

Company Type

Company Type Graph - 7th Genome Editing Therapeutics Summit 2026

Attendee Seniority

Attendees Graph - 7th Genome Editing Therapeutics Summit 2026